# Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis

> **NCT01701466** · PHASE2 · TERMINATED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 14 (actual)

## Conditions studied

- Head and Neck Cancer
- Breast Cancer

## Interventions

- **OTHER:** Aveeno cream
- **OTHER:** Flamazine cream
- **OTHER:** NeoVIDERM cream

## Key facts

- **NCT ID:** NCT01701466
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2014-05
- **Final completion:** —
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01701466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01701466, "Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01701466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*